Dermatology Times, Psoriasis Supplement, August 2021 (Vol. 42, Supp. 02)

Lack of specific phenotypes complicates verification.

According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.

Some systemic medications may have increased risk for patients during the COVID-19 era, according to a recent Pediatric Dermatology Research Alliance (PeDRA) statement.

Theresa Vavra, PharmD, BCPS, provides studies for some of the most commonly used supplements by patients with psoriasis.

Whitney Linsenmeyer, PhD, RD, LD, provides 3 dietary considerations for patients with psoriasis.

COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.

Holistic options for disease management show improvement in mild psoriasis.

Due to the multimorbid nature of the disease, clinicians must screen, monitor, and aggressively treat the associated comorbidities.